Treasury Chief Reeves Aims for Specific Measures on Living Costs in Forthcoming Financial Plan

Chancellor Rachel Reeves has revealed she is preparing "specific measures to tackle cost of living issues" in next month's financial statement.

In comments to the BBC, she stated that reducing price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the G7 industrialized countries this calendar year and the following year.

Potential Utility Bill Measures

Reports indicate the administration could intervene to bring down utility costs, for instance by slashing the present 5% level of value-added tax applied on energy.

A further option is to lower some of the policy costs currently included in bills.

Fiscal Constraints and Expert Expectations

The administration will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The expectation from most experts is that Reeves will have to introduce tax increases or spending cuts in order to fulfill her self-imposed debt limits.

Earlier on Thursday, analysis indicated there was a twenty-two billion pound shortfall for the Treasury chief to resolve, which is at the lower end of forecasts.

"It is a collective job between the Bank of England and the government to continue tackling some of the causes of inflation," Reeves told reporters in Washington, at the conferences of the IMF and World Bank.

Tax Pledges and Global Concerns

While a great deal of the focus has been on probable tax rises, the Treasury chief said the most recent information from the OBR had not changed her vow to manifesto promises not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable world" with growing international and commercial tensions for the fiscal tax moves, probably to be focused on those "with the broadest shoulders."

International Economic Tensions

Referring to worries about the UK's commercial links with China she said: "Our security interests always are paramount."

Recent statement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led American leader the US President to suggest an extra 100% import tax on imports from China, increasing the prospect of an all-out commercial conflict between the two economic giants.

The American finance chief called China's action "commercial pressure" and "a international production power grab."

Questioned on accepting the American proposal to participate in its conflict with China, Reeves said she was "extremely troubled" by China's actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the international commerce and creates additional challenges."

"In my view there are fields where we should challenge Chinese policies, but there are also important prospects to sell into Chinese markets, including banking sector and other areas of the economy. We've got to achieve that equilibrium appropriate."

The Treasury chief also confirmed she was working with G7 counterparts "regarding our own critical minerals strategy, so that we are reduced dependence."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the cost the NHS pays for medicines could increase as a result of ongoing talks with the US government and its drugs companies, in exchange for lower tariffs and investment.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or scrapping investments in the UK, with some blaming the insufficient payments they are obtaining.

Recently, the government science advisor said the cost the health service spends on drugs would need to increase to halt firms and pharmaceutical investment departing from the UK.

Reeves stated to media: "We have seen as a result of the pricing regime, that clinical trials, innovative medicines have not been available in the United Kingdom in the extent that they are in other continental states."

"Our aim is to guarantee that people receiving treatment from the National Health Service are able to access the best essential treatments in the world. And so we are examining all of that, and... seeking to secure more funding into Britain."